Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors
Summary: Some monoclonal antibodies (mAbs) recovered from survivors of filovirus infections can protect against infection. It is currently unknown whether natural infection also induces some antibodies with the capacity for antibody-dependent enhancement (ADE). A panel of mAbs obtained from human su...
Main Authors: | Natalia A. Kuzmina, Patrick Younan, Pavlo Gilchuk, Rodrigo I. Santos, Andrew I. Flyak, Philipp A. Ilinykh, Kai Huang, Ndongala M. Lubaki, Palaniappan Ramanathan, James E. Crowe, Jr., Alexander Bukreyev |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-08-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124718311252 |
Similar Items
-
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap.
by: Philipp A Ilinykh, et al.
Published: (2018-08-01) -
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
by: Liam B. King, et al.
Published: (2019-04-01) -
Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors
by: Michelle Meyer, et al.
Published: (2018-08-01) -
Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm
by: Patrick Younan, et al.
Published: (2017-09-01) -
The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses.
by: Ndongala Michel Lubaki, et al.
Published: (2016-12-01)